GlassScriptPhysician profile
James A Pollard
NPI 1992799555
$2,172.42
in general payments reported to CMS, 2019-2025
10 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $14.69 · 2021: $242 · 2022: $1,196 · 2024: $204 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,110.21 | 2019-2025 | Gamma, T2 Alpha, Mako |
| Zimmer Biomet Holdings, INC. | $850.33 | 2021-2022 | |
| Djo, LLC | $76.40 | 2021 | |
| Smith+Nephew, INC. | $30.86 | 2019-2025 | Grafix Pl, Stravix |
| Pacira Therapeutics, INC. | $23.34 | 2021 | |
| Radius Health, INC. | $19.59 | 2021 | |
| Bioventus LLC | $16.17 | 2021 | |
| Convatec INC. | $15.67 | 2021 | |
| Horizon Therapeutics Plc | $15.16 | 2021 | |
| Kci USA, INC. | $14.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Pollard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.